European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 40, Status: Authorised

Submitted by Anonymous (not verified) on 16 July 2026 - 13:19

Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 16 July 2026 - 13:00

Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 4, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, PIP number: P/0028/2023

Submitted by Anonymous (not verified) on 16 July 2026 - 9:30

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, PIP number: P/0028/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness